EntryPoint Capital’s KalVista Pharmaceuticals KALV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-11,509	Closed	-$97.5K	–	813
2024 Q4	$97.5K	Sell	11,509 -12,813	-53%	-$109K	0.04%	670
2024 Q3	$282K	Buy	24,322 +20,792	+589%	+$241K	0.16%	275
2024 Q2	$41.6K	Sell	3,530 -4,254	-55%	-$50.1K	0.06%	589
2024 Q1	$92.3K	Buy	+7,784	New	+$92.3K	0.08%	473